Evidence map›Paper›PMID 39009835›Full record

ArticleNature neuroscience2024

Unlocking opioid neuropeptide dynamics with genetically encoded biosensors.

Chunyang Dong, Raajaram Gowrishankar, Yihan Jin, Xinyi Jenny He, Achla Gupta, Huikun Wang, Nilüfer Sayar-Atasoy, Rodolfo J Flores, Karan Mahe, Nikki Tjahjono and 15 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Temporal coding expands the bandwidth of GPCR-mediated neuromodulation.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. A chemogenetic approach for temporal and cell-specific activation of endogenous GPCRs in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Review
  10. Kappa opioid receptor control of motivated behavior revisited.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. A Chemically Stable Photocaged Noradrenaline.ACS chemical neuroscience · 2025
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Chunyang Dong *Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Davis, CA, USA.ORCID http://orcid.org/0000-0002-4820-4454
Raajaram Gowrishankar *Center for the Neurobiology of Addiction, Pain, and Emotion, Departments of Anesthesiology and Pharmacology, University of Washington, Seattle, WA, USA.
Yihan JinDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Davis, CA, USA.
Xinyi Jenny HeDepartment of Neurobiology, School of Biological Sciences, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-3884-0596
Achla GuptaDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Huikun WangUnit on Neuromodulation and Synaptic Integration, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Nilüfer Sayar-AtasoyDepartment of Neuroscience and Pharmacology, Iowa Neuroscience Institute, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, USA.ORCID http://orcid.org/0000-0002-3247-613X
Rodolfo J FloresUnit on Neuromodulation and Synaptic Integration, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Karan MaheDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Davis, CA, USA.
Nikki TjahjonoDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Davis, CA, USA.
Ruqiang LiangDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Davis, CA, USA.
Aaron MarleyDepartment of Pharmacology, University of California San Francisco, San Francisco, CA, USA.
Grace Or MizunoDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Davis, CA, USA.
Darren K LoCollege of Biological Sciences, University of California Davis, Davis, CA, USA.ORCID http://orcid.org/0009-0001-2031-3739
Qingtao SunCold Spring Harbor Laboratory, New York, NY, USA.ORCID http://orcid.org/0000-0003-2167-7750
Jennifer L WhistlerCenter for Neuroscience, University of California Davis, Davis, CA, USA.
Bo LiCold Spring Harbor Laboratory, New York, NY, USA.ORCID http://orcid.org/0000-0002-0154-3088
Ivone GomesDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Mark Von ZastrowDepartment of Pharmacology, University of California San Francisco, San Francisco, CA, USA.
Hugo A TejedaUnit on Neuromodulation and Synaptic Integration, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-2222-6222
Deniz AtasoyDepartment of Neuroscience and Pharmacology, Iowa Neuroscience Institute, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, USA.ORCID http://orcid.org/0000-0002-3325-8820
Lakshmi A DeviDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Michael R BruchasCenter for the Neurobiology of Addiction, Pain, and Emotion, Departments of Anesthesiology and Pharmacology, University of Washington, Seattle, WA, USA. mbruchas@uw.edu.ORCID http://orcid.org/0000-0003-4713-7816
Matthew R BanghartDepartment of Neurobiology, School of Biological Sciences, University of California, San Diego, La Jolla, CA, USA. mbanghart@ucsd.edu.ORCID http://orcid.org/0000-0001-7248-2932
Lin TianDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Davis, CA, USA. lin.tian@mpfi.org.ORCID http://orcid.org/0000-0001-7012-6926

Funding

Unit of Neuromodulation and Synaptic IntegrationZIAMH002970 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI TEJEDA, HUGO · 2019 to 2025
$11.1M
Regulation Of Opioid Receptor Signaling by Endogenous PeptidesR01DA008863 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Lakshmi A Devi, Elyssa Margolis · 1995 to 2026
$6.1M
Post-translational Regulation of Opioid and Cannabinoid Receptors.R37DA008863 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DEVI, LAKSHMI A · 2012 to 2021
$4.6M
DISSECTING DYNORPHIN-KAPPA OPIOID MEDIATED REINSTATEMENT OF NICOTINE PREFERENCER37DA033396 · NIDA · WASHINGTON UNIVERSITY · PI Michael R. Bruchas · 2018 to 2026
$3.8M
Next generation all-optical toolkits for functional analysis of neuropeptide dynamics in neural circuitsU01NS113295 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BANGHART, MATTHEW R., SABATINI, BERNARDO L · 2019 to 2022
$3.7M
Multiplex interrogation of neuromodulatory signaling in behaving animals with enhanced depth and resolutionU01NS120820 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TIAN, LIN, VONZASTROW, MARK E · 2021 to 2024
$3.5M
Genetically encoded indicators for large-scale sensing of neuromodulatory signaling in behaving animalsU01NS103522 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NIMMERJAHN, AXEL, TIAN, LIN · 2017 to 2019
$2.9M
Targeting Ascending Catecholamine Pathways to Prevent HypoglycemiaR01DK126740 · NIDDK · UNIVERSITY OF IOWA · PI ATASOY, DENIZ · 2020 to 2024
$2.3M
Optopharmacology and Sensors for Dissecting Opioid Action In VivoR61DA051489 · NIDA · UNIVERSITY OF WASHINGTON · PI BRUCHAS, MICHAEL R., GU, LIANGCAI · 2020 to 2022
$1.2M
Development of multi-color, bright chemigenetic indicators to image synaptic transmissionR21EY031858 · NEI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TIAN, LIN · 2020 to 2020
$471k
Identifying endogenous peptide ligands for orphan G protein-coupled receptors to explore their roles in CNS disordersR21DA058300 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DEVI, LAKSHMI A · 2022 to 2023
$465k
Post-translational regulation of opioid receptorsR56DA008863 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DEVI, LAKSHMI A · 2007 to 2007
$381k
Intramural NIH HHS ZIA MH002970NIDA NIH HHS R01 DA008863NIDA NIH HHS R21 DA058300NIDA NIH HHS R37 DA008863NIDA NIH HHS R37 DA033396NIDA NIH HHS R56 DA008863NIDA NIH HHS R61 DA051489NIDDK NIH HHS R01 DK126740NINDS NIH HHS U01 NS103522NINDS NIH HHS U01 NS113295NINDS NIH HHS U01 NS120820U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R21EY031858U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) U01NS120820U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) U19NS1237190
6 · The paper itself

Abstract

Neuropeptides are ubiquitous in the nervous system. Research into neuropeptides has been limited by a lack of experimental tools that allow for the precise dissection of their complex and diverse dynamics in a circuit-specific manner. Opioid peptides modulate pain, reward and aversion and as such have high clinical relevance. To illuminate the spatiotemporal dynamics of endogenous opioid signaling in the brain, we developed a class of genetically encoded fluorescence sensors based on kappa, delta and mu opioid receptors: κLight, δLight and µLight, respectively. We characterized the pharmacological profiles of these sensors in mammalian cells and in dissociated neurons. We used κLight to identify electrical stimulation parameters that trigger endogenous opioid release and the spatiotemporal scale of dynorphin volume transmission in brain slices. Using in vivo fiber photometry in mice, we demonstrated the utility of these sensors in detecting optogenetically driven opioid release and observed differential opioid release dynamics in response to fearful and rewarding conditions.

Indexed as

Biosensing TechniquesOptogeneticsAnimalsBrainDynorphinsElectric StimulationHEK293 CellsHumansMaleMiceMice, Inbred C57BLNeuronsNeuropeptidesOpioid PeptidesReceptors, OpioidRewardDynorphinsNeuropeptidesOpioid PeptidesReceptors, Opioid

Identifiers

PMID39009835
PMCPMC11374718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.